Abstract
Background Depression and Coronary Artery Disease (CAD) are highly comorbid conditions. Approximately 40% of individuals who have one diagnosis will also develop the other within their lifetime. Prior research indicates that polygenic risk for depression increases the odds of developing CAD even in the absence of clinical depression. However, the specific genes and pathways involved in comorbid depression-CAD remain unknown.
Results We identified genes that are significantly associated with both depression and CAD, and are enriched for pathways involved in inflammation and for previous association with cardiomyopathy. We observed increased rate of prevalent, but not incident, cardiomyopathy cases in individuals with comorbid depression-CAD compared to those with CAD alone in three electronic large health record (EHR) datasets.
Conclusions The results of our study implicate genetically regulated inflammatory mechanisms in depression-CAD. Our results also raise the hypothesis that depression-associated CAD may be enriched for cardiomyopathy.
Clinical Perspective
What’s New?
Gene associations shared between depression and CAD are enriched for prior association with cardiomyopathy phenotypes.
Cardiomyopathy is significantly more prevalent in individuals with comorbid depression-CAD than in CAD or depression alone.
What are the Clinical Implications?
Our work suggests that individuals with comorbid depression-CAD may benefit from screening for cardiomyopathy.
Competing Interest Statement
JWS is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity), and has received an honorarium for an internal seminar Tempus Labs. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments.
Funding Statement
KS is funded by the American Heart Association Fellowship AHA827137. LKD is supported by R56MH120736. JWS and LKD are supported in part by NIMH R01 H118233. JMS is funded by 1F31MH124306-01A1. QSW was supported by NIH 1R01HL140074.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed by the VUMC IRB and designated as non-human subjects research because of the use of fully de-identified data (IRB# 190418 and IRB# 201609).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Correcting the spelling of an author's name.
Data Availability
The electronic health record data that support the findings of this study are available from Vanderbilt University Medical Center, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the institution with appropriate material transfer agreements or data use agreements and permission of Vanderbilt University Medical Center.
Non-Standard Abbreviations and Acronyms
- CAD
- Coronary artery disease
- CI
- Confidence interval
- CAD
- Coronary Artery Disease
- CVD
- Cardiovascular disease
- HER
- Electronic health record
- GWAS
- Genome-wide association study
- ICD
- International Classification of Diseases
- LD
- Linkage disequilibrium
- MD
- Major depression
- MDD
- Major depressive disorder
- MHC
- Major histocompatibility complex
- MR
- Mendelian randomisation
- OR
- Odds ratio
- PGS
- Polygenic score
- SNP
- Single nucleotide polymorphism
- VUMC
- Vanderbilt University Medical Center
